»ó´Ü¿©¹é
±â»ç (Àüü 235°Ç)
[Deep in Guideline] ½ÅÁßÇÑ Á¢±ÙÀü·« Á¦½Ã¡¤¼¼ºÎÀûÀÎ Ç×Ç÷¼ÒÆÇÀü·« Ãß°¡ ÀÓ¼¼Çü ±âÀÚ 2020-11-02 14:31
[Sub Story]

ÄÝ·¹½ºÅ×·ÑÈí¼ö¾ïÁ¦ ¿¡Á¦Æ¼¹Ìºê

½ºÅ¸Æ¾ º´¿ë ÆÄÆ®³Ê·Î ÀÚ¸®Àâ¾Æ

ÀÌ»óµ· ±âÀÚ 2020-10-13 09:41
[Sub Story] LDL-C ¸ñǥġ ÇÏÇâÁ¶Àý 1µî°ø½ÅÀº ½ºÅ¸Æ¾ ÀÌ»óµ· ±âÀÚ 2020-10-12 18:11
[Deep in Guideline] ȯÀÚ Áß½É Ä¡·áÀü·« °­Á¶ ÀÓ¼¼Çü ±âÀÚ 2020-10-12 17:12
[Journal Briefing] ACS ÈÄ ¿µ¾ç½ÇÁ¶ '°æ°í' ÇãÈñÀ± ±âÀÚ 2020-08-18 10:24
¶óÀÎ
[Drug Review] ÃâÇ÷À§Çè ÁÙÀÌ°í À¯È¿¼º ±Ø´ëÈ­ÇÒ ¼ö ÀÖ¾î¾ß ÀÌ»óµ· ±âÀÚ 2020-08-13 16:16
[Drug Review] À¯È¿¼º¡¤¾ÈÀü¼º ¹ë·±½º °®Ãá Ŭ·ÎÇǵµ±×·¼ ÀÌ»óµ· ±âÀÚ 2020-08-13 16:15
[Deep in Guideline] NOAC Áß½ÉÀÇ Ç×Ç÷ÀüÄ¡·á ±Ç°í ÀÌ»óµ· ±âÀÚ 2020-08-12 14:39
[Journal Briefing] RAS ¾ïÁ¦Á¦´Â '¾ÈÀü', ½ºÆ®·¹½º´Â '»¡°£ºÒ' ÇãÈñÀ± ±âÀÚ 2020-07-19 18:57
[Sub Story] CVD °ö¼ÀÈ¿°ú·Î ¸ÍÀ§ ¶³Ä¡´Â ´ë»çÁõÈıº ÀÌ»óµ· ±âÀÚ 2020-07-19 15:08
¶óÀÎ
[Interview] ¡°ÇÇŸ¹Ù½ºÅ¸Æ¾À¸·Î

Ç÷°ü¡¤´ë»ç ÇýÅà ¸ðµÎ ÀâÀ» ¼ö À־

ÀÌ»óµ· ±âÀÚ 2020-07-19 14:44
[Sub Story] ¿¡Á¦Æ¼¹Ìºê Ãß°¡ÇýÅà ºÃ´õ´Ï¡¦ ÀÌ»óµ· ±âÀÚ 2020-07-19 14:35
[Cover Story]

LDLÄÝ·¹½ºÅ×·Ñ ¸ñǥġ

À¯·´½ÉÀåÇÐȸ vs Çѱ¹ÁöÁúµ¿¸Æ°æÈ­ÇÐȸ

ÀÌ»óµ· ±âÀÚ 2020-05-14 10:57
[Sub Story] LDL-C ¸ñǥġ º¯Ãµ»ç´Â °í°­µµ ½ºÅ¸Æ¾ Ä¡·á»ç ÀÌ»óµ· ±âÀÚ 2020-05-14 10:18
[Sub Story] ¾Æ½Ã¾Æ ȯÀÚ ¡®¸ÂÃãÀü·«¡¯ ÇÇŸ¹Ù½ºÅ¸Æ¾ ÀÓ¼¼Çü ±âÀÚ 2020-05-14 09:52
¶óÀÎ
[Sub Story] ½½±â·Î¿î LDL-C ÁÙÀ̱⠻ýÈ° ÀÌ»óµ· ±âÀÚ 2020-05-14 09:36
[Sub Story] ½É±Ù°æ»öÁõ ȯÀÚ¿¡¼­ Ç÷Àü ¿¹¹æ Àå±â Àü·« THE MOST 2020-01-30 15:58
[Interview] Çѱ¹ÀÎ CVD °ü¸®, LDL-C°¡ ÀüºÎ ¾Æ´Ï´Ù ÀÓ¼¼Çü ±âÀÚ 2020-01-30 10:58
[Conference Report] ¾Æ½Ã¾Æ ½É±Ù°æ»öÁõ ȯÀÚ ¼­¾ç°ú ´Ù¸¥ Á¢±ÙÀü·« ÇÊ¿äÇÏ´Ù ÀÓ¼¼Çü ±âÀÚ 2020-01-02 14:10
[Interview] ¡°ESC, °í¡¤ÃÊ°íÀ§Çè ´ç´¢º´ ȯÀÚµµ LDL-C 50% ÀÌ»ó ³·Ãç¾ß¡± ÀÓ¼¼Çü ±âÀÚ 2019-12-03 15:06
Back to Top